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The relationship between maternal hormones and factors
secreted by the implanting embryo is still controversial. We
have analysed the in-vitro effect of oestradiol and human
embryo-derived histamine-releasing factor (EHRF) on
histamine release from rat uterine mast cells. Rat uterine mast
cells which were preincubated with oestradiol and then
challenged with human EHRF gave histamine release values
two- to threefold higher than those without preincubation.
The enhancement observed was time- and temperature-
dependent. A similar enhancement was obtained with human
sensitized basophils but not with rat peritoneal mast cells.
Oestradiol, used as a direct challenge, did not induce any
histamine release from either rat uterine or peritoneal mast
cells, or from human sensitized basophils. Oestradiol pre-
incubation also enhanced the histamine release induced by
anti-IgE but did not enhance the histamine release induced
by substance P or compound 48/80, two secretagogues that
are not mediated by IgE. Moreover, uterine fragments
derived from rats at various oestrus phases, with different
amounts of endogenous oestrogen, were challenged in vitro
with EHRF. The release of histamine by mast cells was higher
at the proestrus and preimplantation phases than at dioestrus.
All these findings suggest that the interaction of oestradiol
with rat uterine mast cells was capable of enhancing in vitro
the histamine releasing effect of EHRF.
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Introduction
Pregnancy depends on synchronized events, orchestrated by an
early maternal—embryonal dialogue (Adinolfi, 1989). The local
uterine changes occurring at the site of blastocyst implantation
suggest that embryonic signals could be very important (Hore
and Mehrotra, 1988; Weitlauf, 1989). The maternal-embryonal
dialogue is very likely to be controlled by a sequence of
neuro-hormonal events interacting with the immune system (Hall
etal., 1989).
Previous results obtained by our group showed that embryonic
histamine-releasing factor (EHRF) secreted by the human
preimplantation embryo (Cocchiara etal., 1987a,b, 1988a)
interacts with rat uterine mast cells in vitro causing release of
histamine (Cocchiara et al., 1988b). Several studies (Brandon
and Bibby, 1979; Hore and Mehrotra, 1988; Cocchiara et al.,
1988b) report an increase of the number of rat uterine mast cells
and of the total content of uterine histamine, reaching a maximum
during the preimplantation stage and declining when embryo
implantation is established. Moreover, the oestradiol concentra-
tion increases during the preimplantation stage in rats (Yoshinaga
et al., 1969; Findlay, 1983; Hodgen and Itskovitz, 1989), and
some studies suggest that the oestradiol is responsible for the
degranulation of rat uterine mast cells and for the release of
histamine in vivo (Spaziani and Szego, 1959; Green et al., 1964;
Ferrando and Nalbandon, 1968; Gibbons and Chang, 1972).
Conflicting results, as reviewed by Weitlauf (1989), are reported
on the in-vivo role of histamine and mast cells, since Shelesznyak
(1952) suggests that this vasoactive amine can play a key role
in implantation and Spaziani and Szego (1959) suggest a decrease
in the mast cell population and histamine content as a result of
the rise in circulating maternal oestrogen. A role of uterine mast
cells during implantation could be supported by recent data on
the molecules secreted by mast cells in addition to histamine,
such as cytokines (Galli etal., 1991; Fay and Grudzinskas,
1991) and prostaglandins (Kennedy, 1977; Toder et al., 1984;
Loke, 1989).
Observations of this sort have led us to determine whether
oestradiol can influence degranulation of rat uterine mast cells
and whether a factor secreted by the implanting embryo could
be involved in this process. The availability of EHRF preparations
and of uterine mast cells makes it possible to test this hypothesis
in vitro.
Materials and methods
Buffers
HEPES-buffered Tyrode's solution (10 mM HEPES, 137 mM
NaCl. 5.6 mM glucose, 2.7 mM KC1, 0.4 mM NaH2PO4.
1 mM CaCln, 1 mM MgCl2) with 0.3% bovine serum albumin
(BSA) titrated to pH 7.4, was used for the histamine release
experiments and for the collection of peritoneal cells. The same
solution but free of calcium and magnesium ions, was used for
tissue washing. Tris-ACM buffer (0.025 M Tris. 0.12 M NaCl.
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6 x 104 M CaCl2, 0.001 M MgCl2, pH 7.4) with added 0.3%
BSA was used for the histamine release assay from atopic blood
basophils. Phosphate-buffered saline (PBS), 0.05 M pH 7.9, was
used in the histamine single isotope microassay.
Materials
Oestradiol was prepared at a concentration of 200 /ig/ml (Sigma
Chemical Co. Ltd, St Louis, MO, USA) in a stock solution
containing Tyrode's buffer and 60 mg/ml BSA. Sheep anti-rat
IgE was purchased from Tago Inc. (Burlingame, CA, USA). Both
of the anti-IgE were used diluted by 1:100. S-Adenosyl-L-methyl-
[3H]methionine was purchased from Amersham Radiochemical
Centre. UK. EHRF was isolated from human embryo culture
supernatants by means of a heparin —Sepharose column and was
prepared in our laboratory as previously described (Cocchiara
et al., 1987a, 1988a) and used at a concentration of 1 mg/ml.
Briefly, 10 ml obtained from 10 human embryo culture media
(grown in vitro during an in-vitro fertilization programme)
were loaded onto a heparin-Sepharose column. After washing,
the EHRF activity was eluted with 0.5 M NaCl. The activity
was tested by histamine release assay, using human basophils
from atopic donors. Compound 48/80 was obtained from Sigma
and stored as a stock solution of 100 mg/ml in 1% dimethyl
sulphoxide (DMSO).
Animals and tissue source
Wistar female rats (8 weeks old) were purchased from Morini
(Reggio Emilia, Italy). The oestrus cycle was determined daily
by analysis of vaginal smears for at least 9 days. The dark —light
period during which mating occurred was designated night 0 of
pregnancy, followed by day 1 (when mating plugs or vaginal
spermatozoa were observed). The rats were killed and uteri were
removed during different phases of the oestrus cycle or on
different days of pregnancy, placed in cold Tyrode's solution,
cleaned from adherent connective tissue and cut into pieces of
50 mg wet weight by scissors. Uterine fragments were washed
in Ca2+- and Mg2+-free Tyrode's solution.
The peritoneal mast cells were collected by washing the
peritoneal cavity with Tyrode's buffer supplemented with 0.3%
BSA. They were washed in the same buffer and diluted to a final
concentration of 350 000/ml. The basophils were obtained from
venous blood of atopic donors, with their permission.
Histamine release experiments
The effect of histamine secretagogues on rat uterine fragments
of peritoneal mast cells and human atopic blood basophils was
determined. Rat uterine fragments were washed in Tyrode's
buffer, 0.3% BSA final concentration. The samples were pre-
warmed for 10 min at 37°C and incubated at 37°C in Eppendorf
tubes containing 20 y\ of each secretagogue, EHRF, anti-IgE or
buffer alone. After 30 min, the reaction was stopped by addition
of 300 ix\ cold Tyrode's buffer. Rat peritoneal mast cells were
treated as reported previously (Cocchiara et al., 1988b). A 200 /tl
volume of peritoneal cells at 350 000/ml was incubated in
Tyrode's solution with various secretagogues (anti-IgE, EHRF,
substance P, compound 48/80).
Aliquots of 200 fi\ of whole human atopic heparinized blood
were incubated with different secretagogues in 20 /A of Tris —
ACM, 1 x buffer. All the mixtures incubated at 37°C for 30 min
were centrifuged in a Heraeus Sepatech Biofuge 17RS and
triplicate aliquots of 20 /tl of plasma were then removed for
the histamine assay.
When experiments with oestradiol were performed, uterine or
peritoneal mast cells or basophils were preincubated with
oestradiol (1 /ig/ml) for 30 min and then challenged with the
secretagogue for 30 min. As a control, cells were preincubated
with oestradiol for 30 min and challenged with buffer alone
for 30 min.
Histamine release assay
Histamine was assayed by a single isotope enzymatic microassay,
as previously described (Taylor et al., 1980), by using
500 mCi/mmol S-adenosyl-L-methyl-[3H]methionine (SAM) and
a crude preparation of rat kidney histamine-methyl-transferase
(HMT) (Shaff and Beaven, 1979), as previously described (Taylor
et al., 1980; Cocchiara et al., 1988a).
To each triplicate aliquot of supernatant (20 pi) obtained after
release experiments, 10 /il of HMT —SAM solution was added
and the tubes, after a gentle mixing, were incubated at 37°C for
1 h. The reaction was stopped with 10 /xl of 1 N NaOH, and
the [3H]methyl-histamine formed was extracted into 250 /A of
chloroform. After centrifugation at 3000 g for 5 min, the aqueous
phase was removed and the organic phase washed with 100 ft\
of NaOH (1 M) saturated with NaCl. After centrifugation, 150 pi
of the organic phase was transferred to a scintillation vial and
evaporated to dryness. The liquid scintillator was added and the
bound radioactivity determined in a Beckman counter. The total
histamine was determined by boiling the cells or the tissue
fragments for 10 min with 0.05 M phosphate buffer (pH 7.9).
Spontaneous release was calculated by incubating the cells or the
tissue with buffer alone. The level of histamine release was
expressed as a percentage of the total histamine after subtraction
of the level of spontaneously released histamine. The enhance-
ment of histamine release was calculated using the following
formula: (histamine release with stimulus plus oestradiol —
histamine release with stimulus)/total histamine content.
Statistical analysis
Data were expressed as mean ± SEM of at least four repeated
experiments. The experiments were performed in triplicate and
the intra-assay SEM did not exceed 5%. One-way analysis of
variance (ANOVA) was used to determine differences between
groups. When differences existed, the ANOVA analysis was
followed by the two-tailed (unpaired) Student's r-test.
Results
Oestradiol-induced enhancement of histamine release in
response to stimulation with anti-IgE
The effect of oestradiol on histamine release was initially analysed
using human basophils and anti-human IgE since this is a
convenient experimental model. Kinetic experiments showed that
oestradiol preincubation enhanced the histamine release in
response to stimulation with anti-IgE in a time-dependent manner.
The enhancement obtained after 60 min of oestradiol pre-
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incubation was twofold higher (50%) than after preincubation
for 0 min (27%) (Figure 1). The same cells, preincubated for
different time periods with buffer instead of oestradiol released
the same amount of histamine on challenge with anti-IgE (Figure
1). Histamine release was not observed when the basophils were
preincubated with oestradiol but without any anti-IgE challenge
(Figure 1). The statistical significance of the oestradiol enhance-
ment was evaluated in experiments performed with basophils
from 12 atopic subjects. The variability between the group means
shown in Table I (anti-IgE and oestradiol + anti-IgE) was
significantly larger than the average variability within the different
treatment groups. There were very significant differences among
the groups (P = 0.0023). Moreover, analysis using ANOVA was
identical to results of the unpaired two-tailed /-test.
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Fig. 1. Time-dependent enhancement of histamine release by
oestradiol from leukocytes (human basophils). The cells were
preincubated with 1 /tg/ml of oestradiol ( • ) or buffer (A) for
various times and then stimulated with anti-IgE (1:100) for 30 min.
The values of histamine release obtained by challenge with
oestradiol are also reported ( • ) . Data are the mean ± SEM of
four separate experiments.
Similar results were obtained using rat peritoneal mast cells
(data not shown) and rat uterine fragments as the source of mast
cells instead of human basophils.
Three representative experiments showing significant
enhancement of histamine release upon preincubation with
oestradiol and subsequent challenge with anti-IgE are reported
in Table II (P < 0.01).
Oestradiol-induced enhancement of histamine release in
response to stimulation with EHRF
The rat mast cells and the human basophils were preincubated
with oestradiol and then challenged with EHRF. The uterine mast
cells obtained from 30 rats gave a histamine release induced by
EHRF of 14 ± 4%. This release was always enhanced by
preincubation with oestradiol, giving a value of 26 ± 7% (Figure
2). Human basophils from seven atopic donors showed histamine
release values when challenged with EHRF of 15 ± 5%, which
increased to 37 ± 9% when preincubated with oestradiol. The
peritoneal mast cells did not release histamine when challenged
with either EHRF or oestradiol + EHRF. The standard deviation
among the values obtained from different subjects was quite high,
suggesting that each subject had a different sensitivity. However,
the values obtained in the presence of oestradiol were significantly
higher than the controls without the oestradiol preincubation
(P < 0.01).
To evaluate whether there was any correlation between the
in-vitro histamine release results and the in-vivo oestrogen
variation, the following experiments were performed. Two
different phases of the reproductive cycle were analysed:
proestrus, when the oestradiol concentration was maximal and
dioestrus, when oestradiol is absent or at a very low level. In
addition, we analysed day 4 of pregnancy (preimplantation stage),
when the oestradiol reaches the maximum concentration during
pregnancy. At proestrus, the histamine release induced by
anti-IgE and EHRF was 16 ± 3% and 18 ± 4% respectively.
These values were higher than the values obtained in dioestrus
when the histamine release by either anti-IgE or EHRF challenge
was only 6%. At the preimplantation stage, the histamine release
induced by anti-IgE was 16 ± 4% and by EHRF 31 ± 6 %
Table I.
Donors
1
2
3
4
5
6
7
8
9
10
11
12
Enhancement of histamine release by basophils
Spontaneous histamine release
ng/ml ± SEM
16 ± 1.3
33 ± 2
24 2 ± 4
22 ± 5.2
20 ± 4.3
11.7 ± 1.2
26 ± 1 . 5
28 ± 1 . 3
24 ± 1.6
12 ± 1 1
7.4 ± 0.9
11 ± 1
challenged with anti-IgE.
Total
ng/ml
92.7
147
249
170
163
136
269
143
148
114
115
129
listamine
± SEM
± 5
± 3.2
± 10.5
± 9.7
± 15.3
± 9.2
± 11.2
± 6.1
± 5.8
± 6.9
± 7.4
± 5 8
with or without preincubation
Anti-IgE
ng/ml ± SEM (%)
29.55 ± 3 (17)
79.6 ± 4.2 (40)
44 8 ± 2 . 5 (9)
121 ± 7.3 (66)
73.4 ± 4.1 (37)
32 ± 1.8(16)
80.3 ± 6.2 (22)
91.3 ± 5.5(55)
62.3 ± 4.9 (30)
50.2 ± 3.2 (37)
43.8 ± 2.8 (45)
40 3 ± 3 . 4 (27)
with oestradiol
Oestradiol + anti-IgE
ng/ml ± SEM (%)
45.5 ± 3.2 (38)
124 ± 9.6 (80)
103 3 ± 11.1 (35)
138 ± 9 5 (78)
116.8 ± 8.7 (68)
88 ± 5.2 (61)
113 ± 9.3 (35)
126 ± 8 (85)
92.5 ± 4 (55)
70.4 ± 8.2 (57)
72.5 ± 4.3 (59)
60 7 ± 5.2 (41)
Enhancement
(%)
17
30
23
10
26
41
12
24
20
18
25
16
Values of histamine release are expressed as ng/ml (mean ± SEM of triplicate experiments). The percentage histamine release [indicated as (%)] with
oestradiol plus anti-IgE was significantly higher (P < 0.01) than data obtained with anti-IgE alone.
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1 5
18.6
34.1
1.7
15 1
30 2
1.3
8.6
22 1
of histamine
± SEM
± 0 07
± 1 5
± 2.7
± 0.9
± 1.2
± 2.2
± 0.07
± 0.8
± 1.8
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50
Uterine fragments were (+) or were not ( —) preincubated with 1 /ig/ml
oestradiol for 30 min and then challenged with anti-IgE. Results are the
mean ± SEM of triplicate experiments The histamine release obtained in
the presence of oestradiol was significantly higher (P < 0.01) than the
control without oestradiol.
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Fig. 2. Effect of oestradiol preincubation on EHRF-induced
histamine release from basophils, peritoneal mast cells and uterine
fragments. Cells were preincubated (S ) or not preincubated (S )
with 1 /xg/ml oestradiol for 30 min and stimulated with EHRF for
30 min. Values of histamine release obtained with oestradiol alone
( • ) are also shown. The data are expressed as mean ± SEM of
different experiments. The values from basophils and uterine
fragments of EHRF-induced histamine release after preincubation
with oestradiol were significantly higher than the control without
preincubation (P < 0.01).
(Figure 3). As a control, oestradiol used alone did not induce
any histamine release from the uterine fragments (Figure 3).
In experiments designed to understand the mechanism(s)
involved in the enhancement of the histamine release by
oestradiol, we found that the effect was temperature dependent
in the same fashion as the anti-IgE-induced histamine release
(Table III).
Histamine release induced by substance P and compound 48/80
was not enhanced by oestradiol
Two non-IgE mediated secretagogues, such as substance P and
compound 48/80, were used instead of the anti-IgE, to evaluate
PROESTRUS OIESTRUS PREIMPLANTATION
Fig. 3 . Effect of oestradiol on histamine release by uterine
fragments during the different phases of the reproductive cycle.
Uterine fragments at proestrus, dioestrus and preimplantation phase
(day 4 of pregnancy) were stimulated with oestradiol ( • ) , anti-IgE
( • ) or EHRF (ED) for 30 min. The results are the mean ± SEM
of five different experiments.
Table III. Different effects of oestradiol preincubation on peritoneal mast
cells stimulated with anti-IgE, substance P or compound 48/80
Histamine release
Spontaneous release (Tyrode's)
Oestradiol (1 /tg/ml)
Tyrode's + anti-IgE
Oestradiol (1 ixg/ml) + anti-IgE
Oestradiol (1 /*g/ml) (4°C) + anti-IgE (4°C)
Oestradiol (1 /tg/ml) (4°C) + anti-IgE (37°C)
Substance P (25 /tM)
Oestradiol (1 ^g/ml) + substance P (25 /iM)
Compound 48/80 (10 /ig/ml)
Oestradiol (1 /tg/ml) + compound 48/80
Total histamine
Peritoneal mast cells were or were not preincubated (37 °C) with oestradiol
(1 ^g/ml) for 30 min and then challenged with anti-IgE, substance P or
compound 48/80 Controls comprised cells preincubated with oestradiol at
4°C + anti-IgE at 4°C or with oestradiol at 4°C + anti-IgE at 37°C. The
results are expressed as ng of histamine released per ml of assay (n = 3).
The percentage of total histamine was calculated after subtraction of
spontaneous release.
whether the IgE molecules were involved in the oestradiol-
mediated enhancement. When different concentrations of
oestradiol and substance P or compound 48/80 were used, no
enhancement of histamine release was detected. These results
are summarized in Table III where the results with only one
concentration of oestradiol (1 ^g/ml) and secretagogue are shown.
The standard deviation among the results obtained from different
individuals was quite high, suggesting that each had a different
sensitivity. However, the values obtained in the presence of
oestradiol were significantly higher than the controls made
without oestradiol preincubation (P < 0.001).
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6.25
7.3
27.0
46.0
6.0
25.6
54.6
41.6
39.0
37 5
88.0
±
±
±
±
±
±
±
±
±
±
±
±
SEM)
0.5
0.9
1.8
2.3
0.4
0 5
2.2
1.9
0.7
1.4
2.1
(%)
_
1.2
25.0
48.0
0
24
59 0
43 0
40.0
38.0
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The effect of oestradiol on the enhancement of mast cell
histamine release induced by EHRF and anti-IgE was not
observed when two non-IgE mediated secretagogues, such as
compound 48/80 and substance P, were used. Therefore, these
data suggest that the oestradiol was probably involved in the
exposition of receptors of the IgE molecule present on the
basophil and mast cell surface and specifically interacting with
EHRF and anti-IgE. In addition, this finding provides evidence
that a signal from the human embryo (EHRF) could interact with
IgE molecules present on the surface of the maternal uterine cells.
Oestradiol, although capable of enhancing histamine release
induced by specific secretagogues, was not capable of directly
inducing histamine release in vitro. This result is in contrast with
the in-vivo data reported in the literature. As is well known, the
endogenous oestradiol concentration changes during the oestrus
cycle. Several workers suggest that the mast cell population and
the histamine content decrease as a result of circulating oestrogen
(Levier and Spaziani, 1966; Gibbons and Chang, 1972).
A relationship between the number of uterine mast cells and
the different phases of the reproductive cycle has been established
in vivo (Gibbons and Chang, 1972; Brandon and Bibby, 1979;
Brandon and Evans, 1983). The number increases from day 3
to day 4 of pregnancy and then decreases around the time of
blastocyst attachment (De Feo, 1967; Brandon and Bibby, 1979).
Discussion
The present study demonstrates that oestradiol preincubation
in vitro enhances the histamine-releasing action of EHRF as well
as anti-IgE on human basophils and rat uterine mast cells. The
histamine release from the uterine mast cells induced by EHRF
was higher at the proestrus and preimplantation stages of the
reproductive cycle than at dioestrus.
Previous studies made by our group showed that pre-embryos
growing in vitro produce a histamine-releasing factor (EHRF)
from the 2-cell to the 8-cell stage in humans (Cocchiara et al.,
1987a,b, 1988a,b), and from the 2-cell to the blastocyst in rats
(preliminary results), and it was active as a histamine releaser
in human basophils and rat uterine mast cells. The human and
rat EHRF showed similar activity and there was cross-species
reactivity. The latter is not surprising or unusual, since it has
been reported in the literature and confirmed by several
laboratories that IgE receptors in human cultured basophils bind
both human and rodent IgE with comparable affinity (Ishizaka
etal., 1985).
The human EHRF, while capable of inducing histamine release
from human basophils and rat uterine mast cells, was inactive
when rat peritoneal mast cells were used as the target cells. A
tentative explanation could be that the local environment or
tissue-specific differences in differentiation might modify the cell
surface specificity, resulting in mast cell heterogeneity, as
reported in the literature (Befus, 1986).
The rat uterine mast cells preincubated with oestradiol and then
challenged with human EHRF gave histamine release values
which were two- to threefold higher than values obtained without
preincubation. Brandon and Bibby (1979) observed that the
number of mast cells increases during the pre-attachment phase
of pregnancy to reach a maximum around the time of blastocyst
attachment and then decreases during the attachment phase of
pregnancy. They claim that the reduction in mast cell number
occurred both within and between attachment sites, suggesting
the presence of a stimulus of maternal origin. However, more
recently Hore and Mehrotra (1988) clearly demonstrated that the
fall in the mast cell number in implanting sites was higher than
in the interimplantation area. Therefore, a factor, or the presence
of the blastocyst itself could cause the localized cell depletion.
The results reported in this paper strongly suggest that, in vitro,
oestradiol used alone or as a secretagogue is completely inactive.
Moreover, when uterine tissue fragments from rat uteri at
different oestrus phases were used, different results were
obtained. The endogenous oestradiol concentration was higher
at proestrus and during the preimplantation stage and lower at
dioestrus. When the uterine fragments containing mast cells were
collected at proestrus or at the preimplantation stage and then
challenged with EHRF in vitro, the resulting histamine release
values were higher than at dioestrus stage. A tentative explanation
is that the uterine mast cells in a milieu with a higher oestradiol
concentration become more reactive on exposure to the EHRF
challenge. The coincidence of the timing of the higher concen-
tration of oestradiol during the preimplantation phase, the number
of mast cells and the EHRF secretion by the preimplantation
embryo, would suggest a probable in-vivo role of the combined
action of oestradiol and EHRF. The high number of target uterine
mast cells during the preimplantation stage would amplify the
EHRF message sent by the implanting embryo, by the secretion
of molecules contained in the mast cells. However, the percentage
of enhancement of the histamine release by oestradiol, found at
the preimplantation and proestrus phases, cannot depend on the
higher mast cell concentration, since the number of mast cells
found at proestrus was quite similar to or lower than at dioestrus.
Of particular interest could be the data reported in this paper
on the in-vitro effect of oestradiol and EHRF on uterine
mast cells, which may support an in-vivo role during embryo
implantation of EHRF and uterine mast cells. The data could
also help to clarify the relationship between maternal hormones
and the factor(s) secreted by the implanting embryo.
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